ABOUT


The fourth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2019 will take place February 28 - March 2 at the Hilton Anatole in Dallas, Texas.

Themed “Precision Medicine Approaches for MS: Scientific Principles to Clinical Application,” this CME accredited meeting stands apart from many traditional medical meetings by offering a singular track of scientific and clinical presentations in an interactive environment, as well as numerous networking opportunities. Highlights of the Forum include the Kenneth P. Johnson Memorial Lecture and the National Multiple Sclerosis Society (NMSS) Barancik Award presentation and talk. In addition, two poster sessions will showcase approximately 200 posters.

ACTRIMS is committed to fostering the careers of Young Investigators with an interest in MS. The first session of the Forum is composed of platform presentations by Young Investigators who will be selected based on a review of the submitted abstracts. In addition, junior faculty, fellows and students who submit abstracts are eligible for an education grant to support their attendance. Neurologists in training will learn about career paths in clinical and investigative neuroimmunology through the pre-conference event, "Neurology Resident Summit in Multiple Sclerosis.”

ACTRIMS Forum 2019 will provide an excellent opportunity to interact with scientists and clinicians at the cutting edge of MS research. The inaugural ACTRIMS Forum, held in New Orleans in February 2016, was a great success with over 600 participants, well surpassing the original projected attendance of 250. Year after year, the ACTRIMS Forum continues to have record-breaking participation with nearly 1,000 attendees in 2018. Approximately 1,100 attendees are expected in 2019 as ACTRIMS continues to further its mission of providing leadership in the field of multiple sclerosis and other demyelinating diseases.

GOALS

  • Discuss precision-medicine approaches for MS diagnosis and management
  • Review current knowledge of biomarkers differentiating different forms of MS and MS from other disorders
  • Understand clinical, biological and radiological predictors of MS disease course
  • Examine emerging biotechnologies applicable to MS
  • Discuss algorithms and predictive models for MS management
  • Provide mentorship to trainees and junior faculty interested in a career in MS research and/or clinical practice
  • Ensure that research findings are disseminated to various stakeholder groups, including MS care providers, researchers, media outlets, social media, and patient advocacy groups

REASONS TO ATTEND

  • Become informed in the latest knowledge in scientific principles to clinical application approaches
  • Get career advice from established investigators on how to launch a career as a young investigator
  • Optimize MS management
  • Network with clinical and scientific experts in the field of MS and neuroimmunology

WHO SHOULD ATTEND

The Forum will be of value to researchers, clinicians, residents, students, postdoctoral fellows, and patient advocates who have an interest in precision medicine approaches for MS and in the future of disease modifying therapy.